Cargando…

Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy

Purpose: To compare the efficacy and safety of 6-weekly and 12-weekly intravenous methylprednisolone (IVMP) regimens in moderate-to-severe, active thyroid-associated orbitopathy (TAO) patients. Basic Procedures: Retrospective comparative study of patients who received IVMP between January 2011 and J...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Kenneth K. H., Aljufairi, Fatema Mohamed Ali Abdulla, Li, Chi Lai, Ngai, Amanda K. Y., Yeung, Carly S. K., Fong, Ryan H. Y., Yip, Wilson W. K., Young, Alvin L., Pang, Chi Pui, Chong, Kelvin K. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179467/ https://www.ncbi.nlm.nih.gov/pubmed/37176682 http://dx.doi.org/10.3390/jcm12093244

Ejemplares similares

Genetic Associations of Interleukin-related Genes with Graves’ Ophthalmopathy: a Systematic Review and Meta-analysis
por: Wong, Kah Hie, et al.
Publicado: (2015)

Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy
por: Liu, Xiaomei, et al.
Publicado: (2016)

Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with vasculitis of rheumatic disease
por: Rouster-Stevens, KA, et al.
Publicado: (2005)

Influence of 4‐week or 12‐week glucocorticoid treatment on metabolic changes in patients with active moderate‐to‐severe thyroid‐associated ophthalmopathy
por: Chen, Xiaoman, et al.
Publicado: (2021)

Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
por: Philip, Rajeev, et al.
Publicado: (2013)

Effects of one-year once-weekly high-intensity interval training on body adiposity and liver fat in adults with central obesity: Study protocol for a randomized controlled trial
por: Chin, Edwin C., et al.
Publicado: (2022)

Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone
por: Qin, L., et al.
Publicado: (2006)

Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.
por: Chi, K. H., et al.
Publicado: (1998)

Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
por: Liu, Ping, et al.
Publicado: (2021)

Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
por: Harsløf, Torben, et al.
Publicado: (2023)

Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment for 5 weeks at the early age.
por: Kim, J. Y., et al.
Publicado: (1997)

A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours
por: Wachters, F M, et al.
Publicado: (2004)

Ocular Surface Changes in Treatment-Naive Thyroid Eye Disease
por: Liao, Xulin, et al.
Publicado: (2023)

Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis
por: Wong, Nicole Tsz Yan, et al.
Publicado: (2023)

Intravenous Glucocorticoid Treatment for Korean Graves' Ophthalmopathy Patients
por: Ahn, Hwa Young, et al.
Publicado: (2020)

Toxicity after prolonged (more than four weeks) administration of intravenous colistin
por: Falagas, Matthew E, et al.
Publicado: (2005)

Case series: MRD negativity assessment using (11)C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma
por: Ngai, Cheong, et al.
Publicado: (2021)

Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
por: Penta, Laura, et al.
Publicado: (2019)

Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis
por: Ghoraba, Hashem H, et al.
Publicado: (2022)

Clinical Significance of Corneal Striae in Thyroid Associated Orbitopathy
por: Liao, Xulin, et al.
Publicado: (2023)

Investigating the Impact of COVID-19 Infection on Dry Eye Parameters
por: Liao, Xulin, et al.
Publicado: (2023)

A 24‐week study to evaluate the efficacy and safety of once‐weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD‐8)
por: Dungan, K. M., et al.
Publicado: (2016)

Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients
por: Soo, Y. O. Y., et al.
Publicado: (2004)

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
por: Jeung, H-C, et al.
Publicado: (2007)

Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis
por: Landry, Kara K, et al.
Publicado: (2022)

Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws
por: Yoshiga, D., et al.
Publicado: (2013)

Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy
por: Higashiyama, Tomoaki, et al.
Publicado: (2016)

Intravenous pulse methylprednisolone for the treatment of severe COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2023)

Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension
por: Jin, S.‐M., et al.
Publicado: (2015)

Growth hormone replacement therapy in adults with growth hormone deficiency; thrice weekly low dose administration.
por: Chung, Y. S., et al.
Publicado: (1994)

Isolated Unilateral Orbital Compression Syndrome in A 19-Year-Old Male With Homozygous Sickle Cell Disease
por: Almukhtar, Fatema M, et al.
Publicado: (2021)

Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
por: Sugimoto, T., et al.
Publicado: (2014)

Neck pain patterns and subgrouping based on weekly SMS-derived trajectories
por: Irgens, P., et al.
Publicado: (2020)

An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumors
por: Murakami, H., et al.
Publicado: (2014)

Intravenous Methylprednisolone Versus Oral Prednisolone for West Syndrome: A Randomized Open-Label Trial
por: Kapoor, Dipti, et al.
Publicado: (2021)

Treatment of postoperative lung injury in patients with SIRS by methylprednisolone
por: Sumida, M, et al.
Publicado: (1998)

Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507
por: Sekine, I, et al.
Publicado: (2003)

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule
por: Awada, A, et al.
Publicado: (1999)

Effect of inhaled azodicarbonamide on F344N rats and B6C3F(1) mice with 2-week and 13-week inhalation exposures()
por: Medinsky, M.A., et al.
Publicado: (1990)

High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
por: Kawada, Sanami, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3ldamb2ic3t6lnthdu6bb0grtr